← Leaderboards
Ellen M Cooper
Boston University Medical Campus
$33,386
Attributed
$33,386
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $22.5K · FY2005–07$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
Funding mix
By agency
NIH$33,386 · 5
By mechanism
M01$33,386 · 5
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Stephen I. Pelton$1,352,372
- Suryaram Gummuluru$17,336,670
- Mark H Mirochnick$691,560
- Timothy P Cooley$60,974
- Josiane Fofana$69,812
Others in their field
Top investigators on “Adherence (Attribute)”
- Jeffrey P Krischer · University Of South Florida$120,978,923
- David Heimbrook · Leidos Biomedical Research, Inc.$88,683,623
- Michelle Vargas · Ppd Development Lp$83,314,632
- Constance Ann Benson · University Of California, San Diego$67,089,733
- David M Nathan · Massachusetts Institute Of Technology$62,205,053
- John M Lachin · George Washington University$50,273,725
Research focus
Adherence (Attribute)AdultAmprenavirArtsBaseBms232632ChildCombined Modality TherapyComputer Retrieval Of Information On Scientific Projects DatabaseDoseDrug CombinationsFamilyFundingGrantHiv-1IndinavirInfantInstitutionIn VitroNelfinavirNucleosidesPatternPeptidomimeticsPharmaceutical Preparations
Grant awards (5)
PHASE I/II STUDY OF PROTEASE INHIBITOR BMS 232632 IN HIV INF INFANTS, CHILDREN$3,239
M01 · FY2007 · RR · contact PI
STUDY OF PROTEASE INHIBITOR BMS 232632 IN HIV INF INFANTS, CHILDREN$7,645
M01 · FY2006 · RR · contact PI
MORPHOLOGIC AND METABOLIC ABNORMALITIES IN HIV INFECTED AND UNIFECTED WOMEN$10,001
M01 · FY2005 · RR
PROTEASE INHIBITOR BMS 232632 IN HIV INF INFANTS, CHILDREN$9,168
M01 · FY2005 · RR
A NOVEL METHOD TO DETERMINE HIV INCIDENCE AMONG YOUTH (ATN 022, VERSION 10)$3,333
M01 · FY2005 · RR